----
Forecast & Rating3 analysts currently cover Inovio Pharma, of which 2 give a positive rating. The average price target is $3.17, about 253.0% upside from the current price of $0.90. Coverage is limited, so the data is for reference only. Data as of Oct 20, 2026; this does not constitute investment advice.
Oct 20, 2026Price forecast
$3.17252.99%
Forecast & RatingBuy
3analysts
- Strong buy33.33%
- Buy33.33%
- Hold33.33%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 1
- Buy
- 1
- Hold
- 1
- Sell
- 0
- Strong sell
- 0
Target price forecast
Forecast dateOct 19, 2026
Forecast met3.5%
Stock price$0.90
Avg. target$3.2
High target$4
Low target$3
- Avg. target
- $3.2
- High target
- $4
- Low target
- $3
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.
